Sherman v. State

905 P.2d 355, 128 Wash. 2d 164, 5 Am. Disabilities Cas. (BNA) 232, 1995 Wash. LEXIS 242
CourtWashington Supreme Court
DecidedNovember 16, 1995
DocketNos. 61645-1; 61268-4
StatusPublished
Cited by138 cases

This text of 905 P.2d 355 (Sherman v. State) is published on Counsel Stack Legal Research, covering Washington Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sherman v. State, 905 P.2d 355, 128 Wash. 2d 164, 5 Am. Disabilities Cas. (BNA) 232, 1995 Wash. LEXIS 242 (Wash. 1995).

Opinion

Pekelis, J.

— This appeal stems from the decision of the University of Washington School of Medicine (the University) to terminate Dr. Scott Sherman, Respondent, [169]*169from its anesthesiology residency program. It is undisputed that Dr. Sherman became chemically dependent on anesthetic narcotics while a resident in the program. Following an incident that raised the suspicion that Dr. Sherman may have used anesthetic narcotics while treating a patient, the University decided to terminate him.

Pursuant to the Washington Administrative Procedure Act (WAPA), RCW 34.05.001-.902, Dr. Sherman brought an action in superior court challenging the University’s termination order. He also moved to disqualify the entire Office of the Attorney General from representing Appellants in this proceeding. The trial court granted this motion. Dr. Sherman later added a number of statutory and common law damages claims, including breach of contract, handicap discrimination, and retaliatory discharge, against the State of Washington, the University of Washington School of Medicine, Dr. Thomas Hornbein, Dr. Bruce C. Gilliland, and President William Gerberding (collectively Appellants).

Without ever reaching the merits of the University’s termination decision, the trial court granted summary judgment to Dr. Sherman on each of these claims and vacated the University’s termination order. Based upon these rulings, the trial court awarded Dr. Sherman almost $900,000 in compensatory damages, punitive damages, and attorneys’ fees and costs. Appellants appeal from the summary judgment. In addition, the Attorney General appeals from the trial court’s order disqualifying the entire Office of the Attorney General from representing Appellants.

We reverse each of these orders and remand for trial Dr. Sherman’s claims of federal and state handicap discrimination, breach of contract, and retaliatory discharge.

Facts

A. Dr. Sherman’s Background

In 1985, Dr. Sherman entered the anesthesiology [170]*170residency program at the University of Washington School of Medicine. The relationship between Dr. Sherman and the University was governed by a contract known as the "University of Washington School of Medicine Graduate Medical Education Program, Residency Position Appointment Agreement” (RPAA). (Clerk’s Papers at 8969.) By virtue of signing the RPAA, Dr. Sherman was also bound by the University of Washington Housestaff Policy Agreement (HSPA), which sets forth the procedures applicable to termination proceedings. (Clerk’s Papers at 8963-66.)

During his residency, Dr. Sherman began using intravenous narcotics. He soon became addicted to synthetic opiates, such as fentanyl and sufentanil, which are commonly used in anesthesiology.

In 1987, the University learned that Dr. Sherman had been diverting anesthetic narcotics for his own use. With the assistance of the Washington Monitored Treatment Program (WMTP),1 the University arranged for an intervention. As a result, Dr. Sherman resigned from the residency program and received treatment for his chemical dependency. He was later readmitted to the program on the condition that he receive long-term treatment from the WMTP.

In September 1988, Dr. Sherman reported a single incident of relapse to Dr. Thomas Hornbein, chair of the Department of Anesthesiology. Dr. Sherman, however, was allowed to remain in the residency program, intensifying his participation in the chemical dependency treatment program.

Prior to July 14, 1989, Dr. Sherman’s residency program performance had been consistently evaluated as satisfac[171]*171tory and he had been encouraged by others, including Dr. Hornbein, to join the faculty after graduation.

B. July 14, 1989, Operating Room Incident

On July 14, 1989, Dr. Bruce S. Gillies, one of Dr. Sherman’s instructors, was supervising Dr. Sherman as he administered anesthesia to a surgery patient. Dr. Sherman was then in the last year of the residency program. According to Dr. Gillies, he had just returned to the operating room after a short break when he happened upon Dr. Sherman, "huddled” next to the operating table drape and holding a syringe. (Clerk’s Papers at 9016.) "When Dr. Gillies asked what he was doing, Dr. Sherman replied that he was "just flushing” the intravenous (IV) tube. (Clerk’s Papers at 9016-18.) Dr. Gillies noticed, however, that Dr. Sherman was holding a syringe with a thirty-gauge needle, which Dr. Gillies believed was too small to accomplish this, and he asked Dr. Sherman about this. According to Dr. Gillies, "Dr. Sherman abruptly pulled the needle off the syringe, attached the syringe to the stopcock of the patient’s intravenous line, and pushed whatever was in the syringe into the patient.” (Clerk’s Papers at 9016.) Dr. Gillies also observed a drop of blood on Dr. Sherman’s left wrist near the " 'anatomical snuff box,’ ” an area where addicts frequently inject drugs. (Clerk’s Papers at 9016.)

After telling Dr. Sherman that he was going to lunch, Dr. Gillies looked back through the operating room window and saw that Dr. Sherman was again huddled next to the operating table drape looking down at his hands. When he returned approximately ten minutes later, Dr. Gillies noticed a piece of gauze with a drop of blood on it and some increased redness on Dr. Sherman’s left wrist as if he had been rubbing it.

Following the incident, Dr. Sherman informed Dr. Gillies that he had disposed of, or "wasted,” an unused portion of the narcotic sufentanil. One month prior, the University had posted a policy requiring the return of any [172]*172unused narcotics to the pharmacy. In the event this could not be done, it was to be disposed of in the presence of a witness and both individuals were to sign a written record of the disposal. Before June 1989, however, the University had not strictly enforced this policy.

Dr. Gillies reported the incident to Dr. Hornbein, who confronted Dr. Sherman. According to Dr. Hornbein, Dr. Sherman’s "immediate, intense response was to deny that there was a problem . . . .” (Admin. R. at 473.) When Dr. Hornbein expressed surprise that Dr. Sherman had wasted narcotics without a witness, Dr. Sherman responded that " 'this was not a very clearly communicated expectation.’ ” (Admin. R. at 475.) Dr. Sherman also "expressed dismay” that Dr. Richard Irons, the WMTP medical director, had not informed him of behavior that would minimize the risk of being questioned about his status. Within an hour, Dr. Sherman provided two separate urine specimens for testing. Although there is a dispute as to where the samples were tested and as to who received the results, it is undisputed that the results of the testing were negative. It is also undisputed that a negative urine test result is inconclusive for determining use of the drugs in question.

C. Dr. Hornbein’s Decision To Terminate Dr. Sherman

Following several meetings with his associates, including members of the anesthesiology department executive committee and Dr. Irons of the WMTP, Dr. Hornbein became convinced that Dr. Sherman had not satisfactorily assumed personal responsibility for his chemical dependency and that his remaining in the program posed a potential risk to patients and himself.

Dr. Hornbein and Dr. John H.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State Of Washington, V. James Robert Spitzer
Court of Appeals of Washington, 2025
State of Washington v. John Thomas Edward Clark
Court of Appeals of Washington, 2024
State Of Washington, V. Rigoberto Galvan
Court of Appeals of Washington, 2024
1223 Spring Street Owners Assoc, V. Randall Steichen
Court of Appeals of Washington, 2023
State Of Washington, V. Lashonne Nicole Davis
Court of Appeals of Washington, 2023
Felix W. Schuck v. Gordon Beck, et ux
Court of Appeals of Washington, 2021
Lori Darlene Shavlik, V. Jolene Marie Jovee
Court of Appeals of Washington, 2021
Mireille Lambert, V. Eric Leitschuck
Court of Appeals of Washington, 2021
Patricia Bell v. Carlo A. Dilorenzo
Court of Appeals of Washington, 2020
Vargas v. Inland Washington, LLC
Washington Supreme Court, 2019
Harper v. State
429 P.3d 1071 (Washington Supreme Court, 2018)
Jdh Cranberries, Llc v. James J. O'hagan, Et Ux
Court of Appeals of Washington, 2017
State Of Washington v. Troy Allen Fisher
Court of Appeals of Washington, 2017
State of Washington v. Daniel Christopher Lazcano
Court of Appeals of Washington, 2017
WSU And Washington State v. Sandra Bernklow
Court of Appeals of Washington, 2017

Cite This Page — Counsel Stack

Bluebook (online)
905 P.2d 355, 128 Wash. 2d 164, 5 Am. Disabilities Cas. (BNA) 232, 1995 Wash. LEXIS 242, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sherman-v-state-wash-1995.